Accurate imaging in the processes of formation and inhibition of drug-induced liver injury by an activable fluorescent probe for ONOO

被引:6
|
作者
Dong, Junming [1 ]
Yang, Yushun [2 ]
Fan, Xiangjun [3 ]
Zhu, Hai-Liang [1 ]
Li, Zhen [1 ]
机构
[1] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, 163 Xianlin Ave, Nanjing 210023, Peoples R China
[2] Jinhua Adv Res Inst, Jinhua 321019, Peoples R China
[3] Nantong Univ, Dept Gen Surg, Affiliated Hosp, Nantong 226001, Peoples R China
关键词
Fluorescent probe; Detection of peroxynitrite; Drug -induced liver injury; Accurate real-time imaging; PEROXYNITRITE; DIAGNOSIS; BIOLOGY; CELLS; METABOLISM; MECHANISMS; MARKERS;
D O I
10.1016/j.mtbio.2023.100689
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Herein, an activable fluorescent probe for peroxynitrite (ONOO-), named NOP, was constructed for the accurate imaging in the processes of formation and inhibition of drug-induced liver injury induced by Acetaminophen (APAP). During the in-solution tests on the general optical properties, the probe showed advantages including good stability, wide pH adaption, high specificity and sensitivity in the monitoring of ONOO-. Subsequently, the probe was further applied in the model mice which used APAP to induce the injury and used inhibiting agents (GSH, Glu, NAC) to treat the induced injury. The construction of the liver injury model was confirmed by the pathological staining and the serum indexes including ALT, AST, ALP, TBIL as well as LDH. During the formation of the drug-induced liver injury, the fluorescence in the red channel enhanced in both time-dependent and dosedependent manners. In inhibition tests, the inhibition of the liver injury exhibited the reduction of the fluorescence intensity. Therefore, NOP could achieve the accurate imaging in the processes of formation and inhibition of drug-induced liver injury. The information here might be helpful for the early diagnosis and the screening of potent treating candidates in liver injury cases.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Drug-induced liver injury
    Raul J. Andrade
    Naga Chalasani
    Einar S. Björnsson
    Ayako Suzuki
    Gerd A. Kullak-Ublick
    Paul B. Watkins
    Harshad Devarbhavi
    Michael Merz
    M. Isabel Lucena
    Neil Kaplowitz
    Guruprasad P. Aithal
    Nature Reviews Disease Primers, 5
  • [42] Drug-induced liver injury
    Abboud, Gebran
    Kaplowitz, Neil
    DRUG SAFETY, 2007, 30 (04) : 277 - 294
  • [43] Drug-Induced Liver Injury
    Gebran Abboud
    Neil Kaplowitz
    Drug Safety, 2007, 30 : 277 - 294
  • [44] Drug-induced liver injury
    Bjornsson, Einar S.
    LAEKNABLADID, 2010, 96 (03): : 175 - 182
  • [45] Drug-induced liver injury
    Kaplowitz, N
    CLINICAL INFECTIOUS DISEASES, 2004, 38 : S44 - S48
  • [46] Drug-induced liver injury
    Kumachev, Alexander
    Wu, Peter E.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2021, 193 (20) : E746 - E747
  • [47] Drug-Induced Liver Injury
    Fisher, Kurt
    Vuppalanchi, Raj
    Saxena, Romil
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2015, 139 (07) : 876 - 887
  • [48] Recent Progress in Fluorescent Sensors for Drug-Induced Liver Injury Assessment
    Chen, Jiao
    Huang, Dongyu
    She, Mengyao
    Wang, Zesi
    Chen, Xi
    Liu, Ping
    Zhang, Shengyong
    Li, Jianli
    ACS SENSORS, 2021, 6 (03) : 628 - 640
  • [49] Drug-Induced Liver Injury in Pregnancy The US Drug-Induced Liver Injury Network Experience
    Masood, Umair
    Venturini, Nicholas
    Nicoletti, Paola
    Dellinger, Andrew
    Kleiner, David
    Bonkovsky, Herbert L.
    Barnhart, Huiman
    Vuppalanchi, Raj
    Rossi, Simona
    Odin, Joseph A.
    Kushner, Tatyana
    OBSTETRICS AND GYNECOLOGY, 2024, 143 (06): : 819 - 823
  • [50] Visualizing ClO- fluctuations in drug-induced liver injury and bacterium via a robust ratiometric fluorescent probe
    He, Chuan
    Liu, Qi
    Zhang, Xue
    Wang, Luan
    Fu, Shuang
    Zhang, Hongguang
    Li, Shuang
    Li, Qi
    Chen, Song
    Hou, Peng
    SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2024, 323